AANEM News Express

AANEM News Express

Science News: Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis

This was a retrospective cohort study conducted in a university hospital in Sweden to compare efficacy between rituximab and conventional immunosuppressants in the refractory and newly diagnosed generalized myasthenia gravis.

Sandra Hearn, MD, Receives 2021 Surinderjit Singh Young Lectureship Award

The AANEM is excited to announce that Sandra Hearn, MD, is the 2021 winner of the Surinderjit Singh Young Lectureship Award. Dr. Hearn was chosen by AANEM President Bonnie Weigert, MD. As part of the award, Dr. Hearn will be a plenary speaker at the 2021 AANEM Annual Meeting in Aurora, Colorado, which will take place October 13-16. Her plenary is called, “Pushing the Boundary of Normal in Electrodiagnostic Interpretation.”


Science News: Which Ultrasound Parameter is More Accurate in the Diagnosis of Carpal Tunnel Syndrome

Ultrasound (US) can be useful to diagnosing carpal tunnel syndrome (CTS). Most US CTS studies have looked at median nerve cross sectional area (CSA). Others use resistive index (RI) or strain ratio (SR) as the criteria. This study compared CSA with RI and SR in CTS.

Science News: Peripheral Nerve Compression Syndromes in Children

Non-traumatic neuropathies of the upper limb are rare in children. Therefore, high quality evidence-based diagnostic guidelines are lacking.


Science News: Serum Neurofilament Light Chain Predicts Long-Term Prognosis in Guillain-Barré Syndrome Patients

This is presented by the International GBS Outcome Study (IGOS), based in Spain. The neurofilament light (NfL) chain is an increasingly studied biomarker for axonal injury, previously studied in GBS. This study evaluates it as a prognostic maker in GBS.

Latest Anthology of Articles from the News Science Editorial Board Now Available

The 2020 News Science Anthology is now available.

Science News: Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series

Eculizumab has been approved and used for AChR antibody positive myasthenia gravis but little is known about its efficacy for AChR seronegative cases.

President Biden’s Initial Health Care Priorities


On Wednesday, January 20, President Joe Biden was sworn in as the 46th President of the United States. In typical presidential fashion, shortly after being sworn in, President Biden issued several executive orders, many of which related directly to health care and, more specifically, the COVID-19 pandemic. Furthermore, as is customary, members of President Trump’s administration, 

Science News: Placebo Effect in Chronic Inflammatory Demyelinating Polyneuropathy: The PATH Study and a Systematic Review

Placebos (pharmacologically inert preparations) are used in treatment trials to assess the true effect of trial medication. Placebo responses have been noted in CIDP trials including the most recent PATH trial investigating subcutaneous IVIG as maintenance therapy.